Brian Evanko - Cigna Corp Chief Financial Officer, Executive Vice President
| CI Stock | USD 344.27 0.99 0.29% |
President
Brian Evanko is Chief Financial Officer, Executive Vice President of Cigna Corp since 2021.
| Age | 47 |
| Tenure | 3 years |
| Address | 900 Cottage Grove Road, Bloomfield, CT, United States, 06002 |
| Phone | 860 226 6000 |
| Web | https://www.cigna.com |
Cigna Corp Management Efficiency
The company has Return on Asset (ROA) of 0.0308 % which means that for every $100 of assets, it generated a profit of $0.0308. This is way below average. Likewise, it shows a return on total equity (ROE) of 0.0897 %, which means that it produced $0.0897 on every 100 dollars invested by current stockholders. Cigna Corp's management efficiency ratios could be used to measure how well Cigna Corp manages its routine affairs as well as how well it operates its assets and liabilities. As of now, Cigna Corp's Return On Tangible Assets are increasing as compared to previous years. The Cigna Corp's current Return On Capital Employed is estimated to increase to 0.05, while Return On Equity is projected to decrease to 0.10. As of now, Cigna Corp's Return On Tangible Assets are increasing as compared to previous years. The Cigna Corp's current Intangibles To Total Assets is estimated to increase to 0.53, while Total Assets are projected to decrease to under 89 B.Similar Executives
| Showing other executives | PRESIDENT Age | ||
| George II | Humana Inc | 55 | |
| Michelle Peluso | CVS Health Corp | 52 | |
| William Fleming | Humana Inc | 53 | |
| Troyen Brennan | CVS Health Corp | 66 | |
| James Clark | CVS Health Corp | 59 | |
| Bethanie Stein | Humana Inc | N/A | |
| Jonathan Roberts | CVS Health Corp | 65 | |
| John III | Humana Inc | N/A | |
| Susan Diamond | Humana Inc | 50 | |
| Thomas Moriarty | CVS Health Corp | 60 | |
| Lisa Bisaccia | CVS Health Corp | 62 | |
| Alan Wheatley | Humana Inc | 51 | |
| Shawn Guertin | CVS Health Corp | 60 | |
| MPP MD | CVS Health Corp | N/A | |
| Joshua Flum | CVS Health Corp | 50 | |
| Cynthia Zipperle | Humana Inc | 58 | |
| Prem Shah | CVS Health Corp | 41 | |
| Eva Boratto | CVS Health Corp | 53 | |
| David Dintenfass | Humana Inc | N/A | |
| James MBA | Humana Inc | 53 | |
| Christopher Hunter | Humana Inc | 52 | |
Management Performance
| Return On Equity | 0.0897 | ||||
| Return On Asset | 0.0308 |
Cigna Corp Leadership Team
Elected by the shareholders, the Cigna Corp's board of directors comprises two types of representatives: Cigna Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cigna. The board's role is to monitor Cigna Corp's management team and ensure that shareholders' interests are well served. Cigna Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cigna Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Arjan Toor, Chief Operations | ||
| Nicole Jones, Executive Vice President, General Counsel | ||
| Matthew Manders, President of U.S. Commercial Markets and Global Health Care Operations | ||
| Donna Zarcone, Independent Director | ||
| Noelle Eder, Executive Vice President, Global Chief Information Officer | ||
| Eric Palmer, Chief Financial Officer, Executive Vice President | ||
| Dean Mirabella, President Markets | ||
| John Webb, President - Health Care | ||
| Cynthia Ryan, Chief Human Resource Officer | ||
| Alexis Jones, Investor Principal | ||
| Mark Boxer, Executive Vice President, Chief Information Officer | ||
| Neesha Hathi, Independent Director | ||
| Adam PharmD, President Services | ||
| Jason Sadler, President of International Markets | ||
| Eric Foss, Independent Director | ||
| Timothy Wentworth, Chief Executive Officer - Evernorth | ||
| Isaiah Harris, Independent Chairman of the Board | ||
| John Murabito, Executive Vice President - Human Resources, Chief Administrative Officer | ||
| Christopher MBA, President Businesses | ||
| Roman Martinez, Independent Director | ||
| William DeLaney, Independent Director | ||
| Kristen Lauria, Executive Vice President, Chief Marketing Officer | ||
| Everett Neville, Executive Vice President, Strategy, Corporate Development and Solutions | ||
| Ralph Giacobbe, Senior Relations | ||
| Phil Austin, Head Markets | ||
| Paul Sanford, Executive Vice President - Operations | ||
| John Partridge, Independent Director | ||
| Mark McClellan, Independent Director | ||
| Kathleen Mazzarella, Independent Director | ||
| Mary CPA, Senior Officer | ||
| MICHAEL TRIPLETT, President - U.S. Commercial | ||
| Steven Miller, Executive Vice President Chief Clinical Officer | ||
| Elder Granger, Independent Director | ||
| Kimberly Ross, Independent Director | ||
| Mary Picerno, Chief Officer | ||
| Eric Wiseman, Lead Independent Director | ||
| Brian Evanko, Chief Financial Officer, Executive Vice President | ||
| Matt Perlberg, Pharmacy President | ||
| Kari Stevens, Chief VP | ||
| David Cordani, CEO and President Director and Member of Executive Committee | ||
| Terese CPA, Senior Officer | ||
| William Roper, Independent Director | ||
| George Kurian, Independent Director | ||
| Charles Berg, President - U.S. Government Business |
Cigna Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cigna Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0897 | ||||
| Return On Asset | 0.0308 | ||||
| Profit Margin | 0.02 % | ||||
| Operating Margin | 0.01 % | ||||
| Current Valuation | 122 B | ||||
| Shares Outstanding | 284.07 M | ||||
| Shares Owned By Insiders | 1.50 % | ||||
| Shares Owned By Institutions | 91.84 % | ||||
| Number Of Shares Shorted | 3.39 M | ||||
| Price To Earning | 13.93 X |
Cigna Corp Investors Sentiment
The influence of Cigna Corp's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Cigna. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Cigna Corp's public news can be used to forecast risks associated with an investment in Cigna. The trend in average sentiment can be used to explain how an investor holding Cigna can time the market purely based on public headlines and social activities around Cigna Corp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Cigna Corp's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Cigna Corp's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Cigna Corp's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Cigna Corp.
Cigna Corp Implied Volatility | 41.81 |
Cigna Corp's implied volatility exposes the market's sentiment of Cigna Corp stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Cigna Corp's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Cigna Corp stock will not fluctuate a lot when Cigna Corp's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Cigna Corp in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Cigna Corp's short interest history, or implied volatility extrapolated from Cigna Corp options trading.
Pair Trading with Cigna Corp
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cigna Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cigna Corp will appreciate offsetting losses from the drop in the long position's value.Moving together with Cigna Stock
| 0.66 | SGHT | Sight Sciences | PairCorr |
Moving against Cigna Stock
| 0.7 | TELA | Tela Bio | PairCorr |
| 0.7 | ZTS | Zoetis Inc | PairCorr |
| 0.54 | RVPHW | Reviva Pharmaceuticals | PairCorr |
| 0.47 | MOLN | Molecular Partners | PairCorr |
| 0.42 | NPCE | Neuropace | PairCorr |
The ability to find closely correlated positions to Cigna Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cigna Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cigna Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cigna Corp to buy it.
The correlation of Cigna Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cigna Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cigna Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cigna Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cigna Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more detail on how to invest in Cigna Stock please use our How to Invest in Cigna Corp guide.You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Complementary Tools for Cigna Stock analysis
When running Cigna Corp's price analysis, check to measure Cigna Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cigna Corp is operating at the current time. Most of Cigna Corp's value examination focuses on studying past and present price action to predict the probability of Cigna Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cigna Corp's price. Additionally, you may evaluate how the addition of Cigna Corp to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
Is Cigna Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cigna Corp. If investors know Cigna will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cigna Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.10) | Dividend Share 5.09 | Earnings Share 12.19 | Revenue Per Share 700.13 | Quarterly Revenue Growth 0.193 |
The market value of Cigna Corp is measured differently than its book value, which is the value of Cigna that is recorded on the company's balance sheet. Investors also form their own opinion of Cigna Corp's value that differs from its market value or its book value, called intrinsic value, which is Cigna Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cigna Corp's market value can be influenced by many factors that don't directly affect Cigna Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cigna Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cigna Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cigna Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.